Yu Wen Liu
Director/Board Member at HANGZHOU TIGERMED CONSULTING CO., LTD
Profile
Yu Wen Liu is currently the Director at Suzhou PANOMIX Biomedical Tech Co., Ltd.
and an Independent Non-Executive Director at Hangzhou Tigermed Consulting Co., Ltd.
Ms. Liu previously held positions as a Director at BrightGene Bio-Medical Technology Co., Ltd., Innovent Biologics, Inc., and MEDx Translational Medicine Co., Ltd.
Additionally, Ms. Liu served as an Independent Director at Adagene, Inc. from 2022 to 2023 and as an Executive Director at Suzhou Industrial Park Biotech Development Co. Ltd.
from 2010 to 2014.
Ms. Liu also worked as a Founding Partner at Bohe Angel Fund.
Ms. Liu received a graduate degree from Fudan University in 2007, BI Norwegian Business School in 2007, and China Pharmaceutical University in 1997.
Yu Wen Liu active positions
| Companies | Position | Start |
|---|---|---|
| HANGZHOU TIGERMED CONSULTING CO., LTD | Director/Board Member | 2024-03-20 |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
 Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China. | Director/Board Member | - |
Former positions of Yu Wen Liu
| Companies | Position | End |
|---|---|---|
| ADAGENE INC. | Director/Board Member | 2023-04-27 |
| Bohe Angel Fund | Corporate Officer/Principal | - |
MEDx Translational Medicine Co., Ltd.
 MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Director/Board Member | - |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Director/Board Member | - |
Suzhou Industrial Park Biotech Development Co. Ltd.
 Suzhou Industrial Park Biotech Development Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Industrial Park Biotech Development Co. Ltd. operates as a Chinese biotechnology company. The private company is located in China. | President | - |
Training of Yu Wen Liu
| China Pharmaceutical University | Graduate Degree |
| Fudan University | Graduate Degree |
| BI Norwegian Business School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| INNOVENT BIOLOGICS, INC. | Health Technology |
| ADAGENE INC. | Health Technology |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
| HANGZHOU TIGERMED CONSULTING CO., LTD | Commercial Services |
| Private companies | 4 |
|---|---|
Suzhou Industrial Park Biotech Development Co. Ltd.
Suzhou Industrial Park Biotech Development Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Industrial Park Biotech Development Co. Ltd. operates as a Chinese biotechnology company. The private company is located in China. | Commercial Services |
MEDx Translational Medicine Co., Ltd.
MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Distribution Services |
| Bohe Angel Fund | Finance |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China. | Commercial Services |
- Stock Market
- Insiders
- Yu Wen Liu
